Top

Published in:

Open Access 01-12-2011 | Editorial

Awakening Australia to Rare Diseases: Symposium report and preliminary outcomes

Authors: Hugh JS Dawkins, Caron M Molster, Leanne M Youngs, Peter C O'Leary

Published in: Orphanet Journal of Rare Diseases | Issue 1/2011

Excerpt

Western Australia recently hosted Australia's inaugural national rare diseases symposium, entitled Awakening Australia to Rare Diseases: Global perspectives on establishing a coordinated approach to a national planhttp://www.raredisease.com.au in the port city of Fremantle, Western Australia from the 17th-20th of April 2011. …

Jaffe A, Zurynski Y, Beville L, Elliott E: Call for a national plan for rare diseases. Journal of Paediatrics and Child Health. 2009, 46 (1-2): 2-4.CrossRefPubMed

Dye D, Brameld KJ, Maxwell S, Goldblatt J, Bower C, Leonard H, Bourke J, Glasson EJ, O'Leary P: The impact of single gene and chromosomal disorders on hospital admissions of children and adolescents: a population based study. Public Health Genomics. 2011, 14 (3): 153-161. 10.1159/000321767.CrossRefPubMed

Dye D, Brameld KJ, Maxwell S, Goldblatt J, Bower C, Leonard H, Bourke J, Glasson EJ, O'Leary P: The impact of single gene and chromosomal disorders on hospital admissions in an adult population. Journal of Community Genetics. 2011, 2: 81-90. 10.1007/s12687-011-0043-3.PubMedCentralCrossRefPubMed

Donaldson L: Rare is common. Annual Report of the Chief Medical Officer. Department of Health, UK; 2009: 38-45.

EURORDIS: Rare diseases understanding this public health priority. European Organisation for Rare Diseases. 2005.

Guillem P, Cans C, Robert-Gnansia E, Aymé S, Jouk PS: Rare diseases in disabled children: an epidemiological survey. Arch Dis Child. 2008, 93 (2): 115-118. 10.1136/adc.2006.104455.CrossRefPubMed

Prevalence of rare diseases: Bibliographic data. Orphanet Report Series. Edited by: Olry A, Aymé S. Orphanet: Paris; 2010.

EU Rare Diseases Task Force: Centres of reference for rare diseases in Europe: State-of-the-art in 2006 and recommendations of the Rare Diseases Task Force. 2006.

Forrest C, Bartek RJ, Rubinstein Y, Groft SC: The case for a global rare-diseases registry. Lancet. 2011, 26;377 (9771): 1057-1059.CrossRef

10.

Olauson A: The Agrenska Centre: a socioeconomic case study of rare diseases. Pharmacogenomics. 2002, 20 (Suppl 3): 73-75.

11.

Rubinstein Y, Groft SC, Bartek R, Brown K, Christensen RA, Collier E, Farber A, Farmer J, Ferguson JH, Forrest CB, Lockhart NC, McCurdy KR, Moore H, Pollen GB, Richesson R, Miller VR, Hull S, Vaught J: Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB). Contemporary Clinical Trials. 2010.

12.

Schiepatti A, Henter JI, Daina E, Aperia A: Why rare diseases are an important medical and social issue. Lancet. 2008, 371: 2039. 10.1016/S0140-6736(08)60872-7.CrossRef

13.

Molster C, Maxwell S, Youngs L, Kyne G, Hope F, Dawkins H, O'Leary P: Blueprint for a deliberative public forum on biobanking policy: Were theoretical principles achievable in practice?. Health Expectations. 2011.

Title: Awakening Australia to Rare Diseases: Symposium report and preliminary outcomes
Authors: Hugh JS Dawkins
Caron M Molster
Leanne M Youngs
Peter C O'Leary
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: Orphanet Journal of Rare Diseases / Issue 1/2011
Electronic ISSN: 1750-1172
DOI: https://doi.org/10.1186/1750-1172-6-57

2024 ASCO Annual Meeting

Springer Medicine

Awakening Australia to Rare Diseases: Symposium report and preliminary outcomes

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2011

Machado-Joseph Disease: from first descriptions to new perspectives

Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France

Pricing and reimbursement of orphan drugs: the need for more transparency

Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA): clinical, molecular and biochemical delineation

Prenatal manifestation and management of a mother and child affected by spondyloperipheral dysplasia with a C-propeptide mutation in COL2A1: case report

"MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trial